Dr. Emily Ko on the Role of Surgery in Endometrial Cancer

Emily Ko, MD, assistant professor of Obstetrics and Gynecology, University of Pennsylvania Health System, discusses the role of surgery in endometrial cancer and the candidacy of patients for the procedure.

Emily Ko, MD, assistant professor of Obstetrics and Gynecology, University of Pennsylvania Health System, discusses the role of surgery in endometrial cancer and the candidacy of patients for the procedure. Unlike other cancer types, Ko says surgery is an upfront treatment for the patients with endometrial cancer. She adds that while surgery is common and normally the best treatment, patient risk factors such as current health and comorbidities must be taken into account prior to a decision being made.

Ko says surgery is the best option due to endometrial cancers normally being confined to the uterus, and being able to rid the patients of their disease upfront generally portends a positive diagnosis. She adds that some forms of endometrial cancer will present early on with metastases, at which point chemotherapy treatment may be a better option.

<<<

View more from the 2016 SGO Annual Meeting

Related Videos
Lisa A. Carey MD, ScM, FASCO
Patrick I. Borgen, MD
Anees Chagpar, MD, MBA, MPH, FACS, FRCS(C)
Steven J. Chmura, MD, PhD
Kevin Kalinsky, MD, MS
Kelly K. Hunt, MD, FACS, FSSO
Laura J. Esserman, MD, MBA
Phillip J. Koo, MD, division chief of Diagnostic Imaging, Northwest Region Oncology physician executive, the Banner MD Anderson Cancer Center in Phoenix, Arizona,
Paul L. Nguyen, MD, senior physician, director, Genitourinary Clinical Center for Radiation Oncology, Dana-Farber Cancer Institute, professor of radiation oncology, Harvard Medical School,
Guru P. Sonpavde, MD, medical director, Genitourinary (GU) Oncology, assistant director, Clinical Research Unit, Christopher K. Glanz Chair, Bladder Cancer Research, AdventHealth Cancer Institute
Related Content